Your search for ‘Spruson & Ferguson’ returned 1,285 results

A decision is expected later this year from the Australian High Court in D'Arcy v Myriad Genetics Inc.

The decision provides commercial certainty and upholds integrity to use one's personal name or identity in their trade.

Businesses across the world can safeguard their rights by early registration of their trade marks locally and overseas.

The Singapore High Court has recently delivered a judgement clarifying, among other things, the legal position concerning shape marks.

Under the Singapore Patents Act as applicable to international patent applications entering into the Singapore National Phase via PCT Chapter II with international filing dates before 1 July 2004, a patent application may proceed to grant provided that the Patent Office receives a copy of the International Preliminary Examination Report (IPER).

Currently, an applicant who wishes to register a trade mark in more than one class of goods and/or services must file separate applications for each class. However, this will change with effect from 2 July 2007.

The Singapore High Court has recently rejected an infringement claim made by the famous American fashion house, Polo/Lauren Company, LP (the plaintiff), against a local fashion retailer, Shop In Department Store Pte Ltd (the defendant).

Discussion of factors that led to decision to refuse to allow post grant amendments to a patent.

The article explains the issues, and the commonly held view of how to calculate straightforward US patent expiry dates.

The main test for allowing an amendment is if it adds new information about the invention.

The draft law takes aim at the widespread use of "registered but not used" marks, which have been difficult to eliminate in China.

This recent APO decision demonstrates that it is indeed possible to successfully oppose a surrender of a patent.

Australia's pharmaceutical patent landscape has reached a critical juncture, with appellate courts reconsidering fundamental principles of patent scope, term extensions, and remedies that will shape originator-generic disputes for the foreseeable future. As the High Court prepares to rule on patent term extensions for formulation patents and new Federal Court practice directions take effect, the strategic calculus for both innovators and generic entrants is being fundamentally rewritten.

Link to country-specific Q&A which provides an overview of Patent Litigation laws & regulations applicable in Australia.

The Patent Office may have an opportunity to reconsider patent eligibility of cDNA with consistent examination practice.

The launch of direct registrations in Australia is delayed and is now likely to take place in the first half of 2020.

The new laws will cover most Australian Government agencies and many private sector and not-for-profit organisations.